Zhichen Pu
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Inflammasome and immune disorders
- RNA modifications and cancer
- Circular RNAs in diseases
- Plant-derived Lignans Synthesis and Bioactivity
- Gut microbiota and health
Papers in
-
- Inflammasome and immune disorders 7
- Plant-derived Lignans Synthesis and Bioactivity 4
- Genetics 7
- Estrogen and related hormone effects 4
- Co-authors
- Haitang Xie (10 shared papers)Weiwei Zhang (4 shared papers)Jun Zhao (3 shared papers)Xiaohu Wang (2 shared papers)Xiaolong Yuan (4 shared papers)Yanhao Liu (3 shared papers)Qin Li (1 shared paper)Hui Sun (2 shared papers)
- Journals
- The American Journal of Chinese Medicine (4 papers)Aging (2 papers)Phytomedicine (2 papers)Evidence-based Complementary and Alternative Medicine (2 papers)Oncotarget (2 papers)
- Partner nations
- China
In The Last Decade
Zhichen Pu
29 papers receiving 729 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 117
- Molecular Biology 378
- Complementary and alternative medicine 41
- Biological Psychiatry 12
- Pharmacology 44
Countries citing papers authored by Zhichen Pu
This map shows the geographic impact of Zhichen Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhichen Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhichen Pu more than expected).
Fields of papers citing papers by Zhichen Pu
This network shows the impact of papers produced by Zhichen Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhichen Pu. The network helps show where Zhichen Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhichen Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 87 | |
| 2 | Systematic understanding of the mechanism and effects of Arctigenin attenuates inflammation in dextran sulfate sodium-induced acute colitis through suppression of NLRP3 inflammasome by SIRT1. | 2019 | 61 |
| 3 | 2020 | 50 | |
| 4 | 2020 | 47 | |
| 5 | 2014 | 46 | |
| 6 | 2021 | 46 | |
| 7 | 2021 | 38 | |
| 8 | 2022 | 37 | |
| 9 | 2021 | 31 | |
| 10 | 2019 | 31 | |
| 11 | 2023 | 30 | |
| 12 | 2022 | 29 | |
| 13 | 2023 | 27 | |
| 14 | 2015 | 21 | |
| 15 | 2024 | 21 | |
| 16 | 2015 | 20 | |
| 17 | 2015 | 20 | |
| 18 | 2017 | 18 | |
| 19 | 2017 | 17 | |
| 20 | 2017 | 17 |
About Zhichen Pu
Zhichen Pu is a scholar working on Molecular Biology, Genetics, Pharmacology, Immunology and Cancer Research, having authored 29 papers that have together received 732 indexed citations. Recurring topics across this work include Inflammasome and immune disorders (7 papers), Drug Transport and Resistance Mechanisms (4 papers), Estrogen and related hormone effects (4 papers), Plant-derived Lignans Synthesis and Bioactivity (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Inflammatory mediators and NSAID effects (2 papers), Cancer, Lipids, and Metabolism (2 papers) and interferon and immune responses (2 papers). The work is most often cited by research in Cancer Research (117 citations), Molecular Biology (378 citations), Complementary and alternative medicine (41 citations), Biological Psychiatry (12 citations) and Pharmacology (44 citations). Zhichen Pu has collaborated with scholars based in China. Frequent co-authors include Haitang Xie, Weiwei Zhang, Jun Zhao, Xiaohu Wang, Xiaolong Yuan, Yanhao Liu, Qin Li, Hui Sun, Qin Yin and Shuangqiao Yang. Their work appears in journals such as The American Journal of Chinese Medicine, Aging, Phytomedicine, Evidence-based Complementary and Alternative Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.